Cancer gene panel (T200.1) sequencing analysis of adult type ovarian granulosa cell tumors (Validation cohort from Hillman, et al)

UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER DEPARTMENT OF GENOMIC MEDICINE - DATA ACCESS AGREEMENT

This agreement discloses the conditions under which any human genomic, proteomic, and immune profiling Data generated by the University of Texas Department of Genomic Medicine is to be accessed from public databases such as dbGAP and EGA. By signing this agreement, you, the User and Associates (collaborators, staff scientists, and trainees) agree to abide by the terms and conditions of data access set out in this agreement. Terms and Conditions: 1. The Data is to be used for research only including analyses of somatic, germline, structural variants, differential expression patterns, and immune infiltrates. 2. The Data is to be stored in an appropriate password-protected computational infrastructure monitored by your institutional information technology group. 3. You, as the User, are a laboratory head, principal investigator and take responsibility for the distribution, use, storage, and management of the Data in question. 4. You, the User and any collaborators, staff scientists, and trainees are to be co-signees of an IRB-protocol for the use of this data. The IRB protocol number should be referenced in the Materials Transfers Agreement. 5. The Materials Transfers Agreement should also state the purpose and goal of the Data usage. 6. You may use the Data for research that could result in intellectual property or commercial product. 7. Confidentiality of Data Subjects will be preserved by you the User and Associates. 8. The accession number of the study under which the Data is received should be incorporated and referenced appropriately in any publication that results from use of the Data. 9. Any breach of this agreement will result in termination and immediate permanent deletion of Data. The Data is subject to international laws.